In patient #1 (Table 2), low level of anti-insulin autoantibody (IAA: 18.7 U/mL) were observed, along with hyperinsulinemia without a corresponding increase in C-peptide levels, a normal BMI, and no clinical signs of hyperinsulinism. The gene discussed is INS; the disease is hyperinsulinism.